Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis ...

There has been a tremendous rise in the number of deaths in Goa due to alcohol-related liver cirrhosis in youngsters, ...

Three common medical conditions may explain why some heavy drinkers develop advanced liver disease while others do not, ...